2023-02-06 10:03:18 AMC AMC Entertainment
02/06/23 02/0610:03 02/06/2310:03 | AMC Theatres announces Sightline at AMC ticket pricing initiativeAMC Theatres announced Sightline at AMC, a ticket pricing initiative based on seat location within each auditorium, which provides AMC moviegoers with multiple options to meet their viewing preferences. With Sightline at AMC, moviegoers now have the option to pay less, or more, for a movie ticket based on their seat selection. The initiative has already rolled out to select AMC locations and will be expanded to all domestic AMC and AMC DINE-IN locations by the end of the year. Sightline at AMC more closely aligns AMC's approach to seat pricing with the experience-based options offered by other entertainment and event venues, and offers three different seat-pricing options: Standard Sightline - these seats are the most common in auditoriums and are available for the traditional cost of a ticket; Value Sightline - these seats are in the front row of the auditorium, as well as select ADA seats in each auditorium, and are available at a lower price than Standard Sightline seats. Value Sightline pricing is only available to AMC Stubs members, including the free tier membership - AMC Insider.; Preferred Sightline - these seats are typically in the middle of the auditorium and are priced at a slight premium to Standard Sightline seats. As an added benefit to AMC's most loyal moviegoers, AMC Stubs A-List members may make reservations in the Preferred Sightline Section at no additional cost. |
|
---|
Periodicals
|
Twitter loses another senior executive in charge of content, safety, WSJ says »
17:46 06/03/23 06/0317:46 06/03/2317:46
TWTR
A second senior executive… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announces updated data from Phase 2 TRiMM-2 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen presents analysis of infections, parameters in Monumen-TAL1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Janssen Pharmaceuticals announced results from Phase 1/2 MonumenTAL-1 study »
17:39 06/03/23 06/0317:39 06/03/2317:39
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune Group announces 3 trial-in-progress abstracts at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Additional Abstracts… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents data from Phase 1 trial of RP2 with nivolumab at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune Group (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Replimune presents RP1 data from IGNYTE trial at ASCO »
17:26 06/03/23 06/0317:26 06/03/2317:26
REPL
Replimune Group
Bristol-Myers
Replimune (REPL)… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
| Healthcare Analysts hold… Story temporarily locked. |
Hot Stocks
|
Janssen announces results from Phase 1b RedirecTT-1 study »
17:18 06/03/23 06/0317:18 06/03/2317:18
JNJ
Johnson & Johnson
The Janssen… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Evaxion's trial of EVX-01 met its primary endpoints of safety, tolerability »
17:09 06/03/23 06/0317:09 06/03/2317:09
EVAX
Evaxion Biotech
Evaxion Biotech presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gracell presents long-term follow up data from study evaluating GC012F »
17:07 06/03/23 06/0317:07 06/03/2317:07
GRCL
Gracell
Gracell Biotechnologies… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Sutro Biopharma announces results from Phase 1 dose-expansion study of luvelta »
17:02 06/03/23 06/0317:02 06/03/2317:02
STRO
Sutro Biopharma
Sutro Biopharma announced… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Equitrans Midstream's Mountain Valley Pipeline to proceed »
16:58 06/03/23 06/0316:58 06/03/2316:58
ETRN
Equitrans Midstream
On June 3, 2023, the… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Cogent Biosciences announces data from ongoing Phase 3 PEAK trial »
16:56 06/03/23 06/0316:56 06/03/2316:56
COGT
Cogent Biosciences
Cogent Biosciences… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Gilead, Arcus announce updated results from interim analysis of ARC-7 study »
16:53 06/03/23 06/0316:53 06/03/2316:53
GILD
Gilead
Arcus Biosciences
Gilead Science (GILD) and… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group participates in a conference call with DA Davidson »
14:27 06/03/23 06/0314:27 06/03/2314:27
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Alamo Group management to meet virtually with DA Davidson »
14:04 06/03/23 06/0314:04 06/03/2314:04
ALG
Alamo Group
Analyst Shlisky holds a… Story temporarily locked. ShowHide Related Items >><<
|
Conference/Events
|
Peoples Bancorp management to meet virtually with DA Davidson »
13:59 06/03/23 06/0313:59 06/03/2313:59
PEBO
Peoples Bancorp
Analyst Navas holds a… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
NewAmsterdam's ROSE2 trial on obicetrapib met primary, secondary endpoints »
13:14 06/03/23 06/0313:14 06/03/2313:14
NAMS
NewAmsterdam
NewAmsterdam Pharma… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Precigen announces Phase 1 data of OTS PRGN-2009 AdenoVerse »
13:09 06/03/23 06/0313:09 06/03/2313:09
PGEN
Precigen
Precigen presented… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Elevation Oncology, CSPC announces initial clinical data for SYSA1801 »
13:02 06/03/23 06/0313:02 06/03/2313:02
ELEV
Elevation Oncology
CSPC
Elevation Oncology (ELEV)… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces data from its VELA trial of BLU-222 »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Blueprint Medicines announces results from its EGFR Programs »
12:59 06/03/23 06/0312:59 06/03/2312:59
BPMC
Blueprint Medicines
Blueprint Medicines… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Merck announces results from Phase 3 KEYNOTE-671 trial evaluating KEYTRUDA »
12:50 06/03/23 06/0312:50 06/03/2312:50
MRK
Merck
Merck, known as MSD… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Allogene Therapeutics presents updated ALLO-501/501A Phase 1 data »
12:45 06/03/23 06/0312:45 06/03/2312:45
ALLO
Allogene Therapeutics
Allogene Therapeutics… Story temporarily locked. ShowHide Related Items >><<
|